Cytodyn Inc (CYDY):企業の財務・戦略的SWOT分析

◆英語タイトル:Cytodyn Inc (CYDY) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH138013FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cytodyn Inc (Cytodyn), formerly RexRay Corp, is a biotechnology company. It develops and commercializes monoclonal antibodies for the treatment of Human Immunodeficiency Virus (HIV) infections. It is investigating Leronlimab (PRO 140), a fully humanized IgG4 monoclonal antibody directed against CCR5, to treat HIV. The company is also evaluating its pipeline against triple negative breast cancer, solid tumors, graft vs host disease, non alcoholic steatohepatitis (NASH), coronavirus and auto immune diseases. CytoDyn uses prostate diagnostic test (PCa test) to determine outcomes of patients diagnosed with prostate cancer. It works in collaboration with pharmaceutical and biotechnology companies to develop its products. The company has operational presence in Florida, the US. Cytodyn is headquartered in Vancouver, Washington, the US.

Cytodyn Inc Key Recent Developments

Apr 07,2021: CytoDyn Signs Exclusive Supply and Distribution Agreement with Biomm S.A. in Brazil for COVID-19 and All Other Leronlimab Indications
Apr 07,2021: CytoDyn Providing Leronlimab to a Philippine Hospital for 28 More COVID-19 Patients under Compassionate Special Permit (CSP)
Apr 05,2021: CytoDyn Completes $28.5 Million Convertible Note Financing with Conversion Rate at $10.00 Per Share Without Warrants to Accelerate Manufacturing of Leronlimab Inventory
Apr 05,2021: First Compassionate Special Permit (CSP) Patient in Philippines Improved Significantly 35 hours After First Injection of Leronlimab and Released 3 Days Later

This comprehensive SWOT profile of Cytodyn Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cytodyn Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Cytodyn Inc – Key Information
Cytodyn Inc – Overview
Cytodyn Inc – Key Employees
Cytodyn Inc – Key Employee Biographies
Cytodyn Inc – Key Operational Heads
Cytodyn Inc – Major Products and Services
Cytodyn Inc – History
Cytodyn Inc – Company Statement
Cytodyn Inc – Locations And Subsidiaries
Cytodyn Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cytodyn Inc – Business Description
Cytodyn Inc – Corporate Strategy
Cytodyn Inc – SWOT Analysis
SWOT Analysis – Overview
Cytodyn Inc – Strengths
Cytodyn Inc – Weaknesses
Cytodyn Inc – Opportunities
Cytodyn Inc – Threats
Cytodyn Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Cytodyn Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cytodyn Inc, Key Information
Cytodyn Inc, Key Ratios
Cytodyn Inc, Share Data
Cytodyn Inc, Major Products and Services
Cytodyn Inc, History
Cytodyn Inc, Key Employees
Cytodyn Inc, Key Employee Biographies
Cytodyn Inc, Key Operational Heads
Cytodyn Inc, Other Locations
Cytodyn Inc, Subsidiaries
Cytodyn Inc, Key Competitors
Cytodyn Inc, SWOT Analysis
Cytodyn Inc, Ratios based on current share price
Cytodyn Inc, Annual Ratios
Cytodyn Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Cytodyn Inc (CYDY):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Reliance Industries Limited:企業の戦略・SWOT・財務情報
    Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Veolia Environnement SA (VIE):電力:M&Aディール及び事業提携情報
    Summary Veolia Environnement SA (Veolia) is an environmental management services company that designs and offers water, waste and energy management solutions. Its service offerings include wastewater and sanitation services, drinking water treatment and distribution and waste management and energy s …
  • Polenergia SA (PEP):電力:M&Aディール及び事業提携情報
    Summary Polenergia SA (Polenergia) formerly Polish Energy Partners SA develops, implements and operates projects related to production of electricity and fuels. It offers services such as project implementation and supervision of construction, management of power facilities, production and sales of …
  • MetLife, Inc.:企業のM&A・事業提携・投資動向
    MetLife, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MetLife, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • EOG Resources, Inc.:企業の戦略・SWOT・財務情報
    EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • City Developments Ltd
    City Developments Ltd - Strategy, SWOT and Corporate Finance Report Summary City Developments Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Leap Therapeutics Inc (LPTX)-医療機器分野:企業M&A・提携分析
    Summary Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that acquires, develops novel therapeutics for cancer research. The company’s pipeline encompasses DKN-01, a humanized monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, and in clinical tria …
  • Verbund AG (VER)-エネルギー分野:企業M&A・提携分析
    Summary Verbund AG (Verbund) is an electricity utility that generates, transmits, trades, and distributes electricity. It generates from renewable energy sources such as hydropower, biomass, wind, and solar power. The company constructs, operates and maintains power plants; trades electricity and ga …
  • JB Hi-Fi Limited (JBH):企業の財務・戦略的SWOT分析
    JB Hi-Fi Limited (JBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • China Longyuan Power Group Corporation Ltd (916):電力:M&Aディール及び事業提携情報
    Summary China Longyuan Power Group Corporation Ltd (CLPGC), a subsidiary of China Energy Investment Corporation Ltd, carries out design, development, construction, management and operation of wind farms. It generates and sells electricity to the local grid companies. The company also operates other …
  • Esperite NV (ESP):企業の財務・戦略的SWOT分析
    Esperite NV (ESP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Greensmith Energy Management Systems LLC:電力:M&Aディール及び事業提携情報
    Summary Greensmith Energy Management Systems, LLC (Greensmith), a subsidiary of Wartsila Corporation, is a provider of energy storage management and services. The company specializes in software and control solutions to operate and manage Distributed Energy Storage Systems (DESS) for utility-scale, …
  • Advantest Corporation (6857):企業の財務・戦略的SWOT分析
    Advantest Corporation (6857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cidara Therapeutics Inc (CDTX):企業の財務・戦略的SWOT分析
    Summary Cidara Therapeutics Inc (Cidara), formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel anti-infectives including immunotherapies. The company's pipeline products include novel echinocandin CD101 IV, for the treatment of systemic candida in …
  • Empire Energy Group Ltd (EEG):企業の財務・戦略的SWOT分析
    Summary Empire Energy Group Ltd (EEGL), formerly Imperial Corp Ltd is an oil and gas company that offers exploration and production programs. The company produces and develops oil and gas assets; and has interest in onshore oil and gas fields in Mid Con property and Appalachia property. It has onsho …
  • Veracyte Inc (VCYT):企業の財務・戦略的SWOT分析
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also …
  • KBC Group NV:企業の戦略・SWOT・財務情報
    KBC Group NV - Strategy, SWOT and Corporate Finance Report Summary KBC Group NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Innoviva Inc (INVA):企業の財務・戦略的SWOT分析
    Innoviva Inc (INVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sinclair Broadcast Group, Inc.:企業の戦略・SWOT・財務情報
    Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • SoftBank Group Corp:企業の戦略・SWOT・財務分析
    SoftBank Group Corp - Strategy, SWOT and Corporate Finance Report Summary SoftBank Group Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆